The experts of the Interstitial Lung Disease program collaborate with a multispecialty team, providing comprehensive care to patients who have multiple needs. Our collaborative nature ensures you have ...

It will provide care for a group of disorders that may progress to pulmonary fibrosis. Asian Hospital and Medical Centre ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease characterized by progressive scarring of lung ...

Despite available treatments, about 25% of patients with SSc-ILD develop PPF, highlighting the need for reliable early treatment response indicators, such as blood biomarkers, which may help ...

The issues relate to the treatment of patients with interstitial lung disease (ILD) under the care of one consultant between 2019 and 2023, with issues first raised five years ago. A hospital ...

previews that experts will discuss critical management strategies for interstitial lung disease and idiopathic pulmonary fibrosis, including the latest diagnosis and treatment protocol ...

with higher treatment rates observed in referral hospitals than in general hospitals or clinics. The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had ...